CLMT News & Analysis
3 articles
Market Mood
S&P upgrades Calumet (CLMT) rating to B- on stronger earnings
S&P Global Ratings upgraded Calumet Specialty Products Partners, L.P. (CLMT) to a B- rating, citing improved earnings performance. This upgrade follows significant enhancements in Calumet's financial health, which were reflected in its recent earnings report. The stronger earnings indicate a positive shift for the company, potentially improving investor confidence and interest. For investors, this upgrade may signal a more favorable outlook for Calumet, influencing stock performance and buying decisions.
Read More: S&P upgrades Calumet (CLMT) rating to B- on stronger earnings
Calumet (CLMT) Stock Hits 52-Week High of $45.20
Calumet stock (CLMT) reached a 52-week high of $45.20. This milestone indicates a significant performance in the market, suggesting investor confidence in the company's prospects. The achievement may attract further attention from both analysts and investors looking at potential growth. A strong performance at this level could lead to increased trading volumes and interest from institutional investors.
Read More: Calumet (CLMT) Stock Hits 52-Week High of $45.20
Calumet (CLMT) Closes $150M Private Placement of Senior Notes
Calumet Inc. (CLMT) closed a private placement of $150 million in 9.75% Senior Notes due 2031 on March 17. The notes were issued at 105% of their par value, leading to net proceeds of approximately $154.9 million after discounts and expenses. The capital raised will be used to repay outstanding borrowings under its revolving credit facility, enhancing financial flexibility in a volatile commodity market. This deal also follows a strong operational performance in 2025 and aligns with plans to reduce 2028 notes debt when the call premium decreases in July.
Read More: Calumet (CLMT) Closes $150M Private Placement of Senior Notes